These data show that, in contrast to the previous view of PD-L2 being restricted to specific immune cell lineages, PD-L2 is expressed by normal urothelium and benign urothelial lesions, and urothelial carcinomas. Here, PDCD1LG2 is linked to urothelial carcinoma.